Moderna and Merck take centre stage at the ESMO 2026 meeting
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Moderna and Merck’s high-profile presentation led the second day of the European Society for Medical Oncology’s 2026 meeting in Madrid, alongside other conference developments including news concerning Amgen’s cancer drug Imdelltra.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu